Chargement en cours...
The journey to understanding incretin systems: Theory, practice and more theory
Accumulating clinical data on incretin‐based dipeptidyl peptidase‐4 inhibitors and glucagon‐like peptide‐1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and di...
Enregistré dans:
| Publié dans: | J Diabetes Investig |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717807/ https://ncbi.nlm.nih.gov/pubmed/31361402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13123 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|